Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06935071 · ClinicalTrials.gov registry record
Endoprosthetic Replacement for Pathological Fractures of the Hip: A 35-year Update
A clinical trial of Hip Fractures and Pathological Fracture, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT06935071: Active study of Hip Fractures and Pathological Fracture, sponsored by Memorial Sloan Kettering Cancer Center.
NCT06935071 is a study of Hip Fractures and Pathological Fracture that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 300 participants, below the 601-participant average among 15 other Hip Fractures trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06935071, a study of Hip Fractures and Pathological Fracture, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will be based on a retrospective review of patients who received endoprosthetic reconstruction for pathologic fracture of the proximal femur. The objectives would be two-fold: (1) to compare rates ofambulation, pain, and survival to the historic cohort and (2) to identify predictors of ambulation in the current population.
Primary Outcome
This study will be based on a retrospective review of patients who received endoprosthetic reconstruction for pathologic fracture of the proximal femur.
Conditions Studied
Interventions
- OTHER Data Collection and Analysis
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2016-08-04 |
| Est. Completion | 2026-08-04 |
What the registry record for NCT06935071 still lists
NCT06935071 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 601-participant average among 15 other Hip Fractures trials with a reported enrollment target (50% lower).
The record links to 4 conditions, with Hip Fractures appearing as the primary indexed condition, and to 1 intervention - of which Data Collection and Analysis is the first listed.
NCT06935071 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06935071 about?
NCT06935071 is a clinical study titled "Endoprosthetic Replacement for Pathological Fractures of the Hip: A 35-year Update". This study will be based on a retrospective review of patients who received endoprosthetic reconstruction for pathologic fracture of the proximal femur. The objectives would be two-fold: (1) to compare rates ofambulation, pain, and survival to the historic cohort and (2) to identify predictors of am...
What is the current status of trial NCT06935071?
This trial is currently active not recruiting. The enrollment target is 300 participants. The study started on 2016-08-04. Estimated completion is 2026-08-04.
What conditions does trial NCT06935071 study?
This clinical trial studies the following conditions: Hip Fractures, Pathological Fracture, Hip Fracture Pathologic, Pathological Fracture of Hip.
What interventions are being tested in trial NCT06935071?
The interventions under investigation include: Data Collection and Analysis (OTHER).
Who is sponsoring clinical trial NCT06935071?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06935071 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hip Fractures
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06935071's enrollment target sits among peer trials
300 8th of 15 higher than 8 of 15 other Hip Fractures trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hip Fractures trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial
RECRUITING · NA
-
Evaluating a Strategy to Improve Pre-Anesthesia Care Discussions (My Anesthesia Choice-Hip Fracture)
RECRUITING · NA
-
Cervical Myelopathy in Hip Fracture Patients
RECRUITING · NA
-
Comparison of Cryoablation of Pericapsular Nerve Group (PENG) to Fascia Iliaca Catheter in Patients With a Hip Fracture
RECRUITING · Phase 4
-
PENG vs Femoral Block for Hip Fracture Analgesia
RECRUITING · NA
-
MDR - PMCF Study for Taperloc Complete Stems
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI